TAYVIEW ORTHOPAEDICS LTDActive

Company number SC713432Private limited companyIncorporated 2021
⚠ Confirmation statement overdue. It was due on 17 Oct 2026.

Key figures

£62,725+25.1%
Net assets 2024/25
+48.1%
Average annual growth 2021/22–2024/25
020 k40 k60 k80 k2021/222022/232023/242024/25

Like most small UK companies, TAYVIEW ORTHOPAEDICS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
050 k100 k2021/222022/232023/242024/25
Filed accounts2021/22–2024/25
2021/222022/232023/242024/25
Total assets42,60668,48469,25780,056
Total liabilities21,9898,82717,91115,981
Net assets / total equity19,31758,05750,14662,725
Average number of employees2222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company during the year under review was specialist medical consultancy.

As described in the company's latest filed accounts.

Summary: TAYVIEW ORTHOPAEDICS LTD

Company

TAYVIEW ORTHOPAEDICS LTD is a private limited company registered with Companies House under company number SC713432. It was incorporated on 27 Oct 2021. Its status is active. The registered office is in Cupar (KY15). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £62,725, up 25.1% on the previous year. Total assets were £80,056 and total liabilities £15,981. The company had an average of 2 employees. Figures are available for 4 financial years (2021/22–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 17 Oct 2026.